Join us in celebrating 30 years of JMCP and advancing the dialogue in managed care pharmacy through research, innovation, and real-world application, fostering collaboration and driving impactful change.
On the evening of March 11, the House of Representatives passed a Continuing Resolution (CR), which funds the federal government at existing levels until Sept. 30.
A coalition of 34 scientific and medical organizations led by the American Association of Immunologists and the American College of Physicians released the following statement.
A new Academy of Managed Care Pharmacy Foundation report, “Emerging Trends Impacting Managed Care Pharmacy,” developed in partnership with Pfizer, warned of significant shifts within managed care pharmacies fueled by AI adoption, drug shortages and affordability challenges.
Use this checklist to explore member communities and upcoming events to start connecting with peers right away.
This calendar is designed to align AMCP programs and resources with the key challenges that managed care pharmacy professionals… or “MCPs” face throughout the year. These programs are designed to provide insights, networking, and professional development to help you stay ahead in managed care pharmacy.
The Protecting Pharmacies in Medicaid Act would prohibit the use of spread pricing arrangements in Medicaid programs. Pharmacy benefit managers (PBMs) would be required to pass through to pharmacies the full amount of the money paid to the PBMs by Medicaid programs, except for a fixed administrative fee. The total reimbursement amount will be determined by a survey of national average drug acquisition costs administered by the Department of Health & Human Services.
On March 12, 2025, the Centers for Medicare & Medicaid Services (CMS) Innovation Center announced the early termination of several payment model trials by December 31, 2025.
In AMCP's latest comments to the FDA, we emphasize the need for standardized public reporting of confirmatory trial progress, ensuring payers and health care providers have the necessary data to make informed coverage decisions. By supporting proactive communication and rigorous confirmatory trials, AMCP aims to balance early access to innovative treatments with patient safety and long-term therapeutic value.
Over the weekend, Congressional leadership released a continuing resolution (CR) that extends government funding at the same level as the previous fiscal year, through September 30. Congress must extend government funding by March 14 to avoid a government shutdown.
